Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview

Taro Pharmaceutical Industries

17/05/2024 21:40

* Taro Pharmaceutical Industries Ltd  TARO.N   TARO.K  is
expected
to show a rise in quarterly revenue when it reports  results on
May 20 for the period ending March 31 2024
    * The Haifa Israel-based   company is expected to report a
6.5% increase in revenue to $156.062 million from $146.59
million a year ago, according to the estimate from one analyst,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Taro Pharmaceutical
Industries
Ltd is for earnings of 31 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $43.00​, above​ its last
closing price of $42.20. ​​​

This summary was machine generated May 17 at 20:40 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)